The global peripheral interventions market continues to witness robust expansion driven by the rising prevalence of peripheral artery disease (PAD), technological advancements in vascular treatment devices, and the growing preference for minimally invasive procedures. According to recent industry estimates, the market was valued at USD 10.11 billion in 2024 and is expected to grow from USD 10.93 billion in 2025 to USD 20.29 billion by 2032, exhibiting an impressive CAGR of 9.23% over the forecast period.

This growth trajectory reflects the increasing adoption of image-guided interventions, expanding geriatric population, and broader clinical use of angioplasty balloons, stents, and atherectomy devices across hospitals, ambulatory surgical centers, and specialty clinics.

Get Full Detailed PDF Report: https://www.kingsresearch.com/report/peripheral-interventions-market-2971 

Market Overview 

Peripheral interventions involve minimally invasive techniques used to diagnose and treat diseases in peripheral blood vessels outside the heart and brain. These procedures are primarily performed to restore proper blood flow, reduce vascular blockages, and treat complications associated with PAD, venous diseases, and other vascular disorders.

The global rise in sedentary lifestyles, diabetes, hypertension, obesity, and smoking has contributed to a higher incidence of PAD, encouraging the adoption of peripheral intervention devices. At the same time, technological advancements such as drug-coated balloons, next-generation stents, hybrid atherectomy systems, and improved imaging modalities are further accelerating market uptake.

Market Dynamics

Key Drivers

1. Rising Prevalence of Peripheral Artery Disease

PAD affects millions globally, especially the elderly population. Increasing awareness, early diagnosis, and easy access to vascular care have propelled demand for high-performance interventional devices.

2. Technological Advancements

Innovations such as drug-eluting stents (DES), bioresorbable scaffolds, improved embolic protection devices, and enhanced catheter designs significantly improve clinical outcomes and reduce restenosis rates, resulting in greater clinical adoption.

3. Shift Toward Minimally Invasive Procedures

Minimally invasive vascular interventions offer advantages such as reduced hospital stays, fewer complications, faster recovery, and enhanced patient satisfaction. This global trend continues to influence hospitals and outpatient centers to expand their interventional portfolios.

4. Growing Geriatric Population

The aging demographic is more prone to vascular diseases. As life expectancy increases worldwide, demand for peripheral interventions is expected to rise consistently.

Challenges

1. High Cost of Advanced Devices

Drug-coated balloons, self-expanding stents, and robotic-assisted systems involve significant costs, limiting adoption in developing markets.

2. Limited Skilled Professionals

A shortage of trained vascular surgeons and interventional radiologists in emerging markets constrains growth potential.

3. Stringent Regulatory Processes

Approval processes for new vascular devices can be lengthy, impacting the introduction of innovative products.

Segmentation Analysis

By Product Type

1. Angioplasty Balloons

Angioplasty balloons hold a significant share due to their extensive use in vessel dilation and PAD treatment. Drug-coated balloons (DCBs) are increasingly preferred because they reduce the risk of restenosis and provide long-term patency.

2. Stents

Stents—including bare-metal stents, drug-eluting stents, and covered stents—are widely used in treating arterial blockages. The innovation in self-expanding and nitinol stents continues to support segment expansion.

3. Atherectomy Devices

Atherectomy devices are gaining traction owing to their ability to remove plaque debris and support vessel preparation. Their use is growing in calcified lesion management, boosting demand.

4. Embolic Protection Devices

These devices play a crucial role in preventing debris from traveling through blood vessels during interventions. Adoption is rising in both peripheral and coronary procedures.

5. Catheters & Guidewires

Essential components in all vascular interventions, this segment benefits from continuous innovation in flexibility, steerability, and safety.

6. Others

Includes thrombectomy devices, vascular closure devices, and support accessories.

By Application

Peripheral Artery Disease (PAD)

PAD remains the largest application segment due to rising disease prevalence and the need for frequent interventional procedures.

Venous Thromboembolism

Deep vein thrombosis and pulmonary embolism cases are growing globally, driving the use of mechanical thrombectomy and catheter-directed therapies.

Aneurysm Repair

Endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) procedures are increasing as alternatives to open surgery.

Others

Includes renal artery stenosis, mesenteric ischemia, and diabetic vascular complications.

By End Use

Hospitals

Hospitals account for the largest market share due to advanced infrastructure, availability of specialized professionals, and higher procedure volumes.

Ambulatory Surgical Centers (ASCs)

ASCs are rapidly emerging as preferred centers for minimally invasive vascular procedures due to cost efficiency and shorter wait times.

Specialty Clinics

Growth in standalone vascular clinics boosts adoption of catheters, guidewires, balloons, and atherectomy devices.

Regional Analysis (2025–2032)

North America

North America remains a leading region due to strong healthcare infrastructure, high PAD prevalence, and rapid adoption of advanced interventional technologies. The presence of major manufacturers and favorable reimbursement supports continued growth.

Europe

Europe demonstrates strong demand driven by rising geriatric population, supportive government programs, and high adoption of minimally invasive vascular procedures.

Asia Pacific

Asia Pacific is projected to witness the fastest growth due to improving healthcare infrastructure, increasing vascular disease burden, and rapid expansion of medical device companies across India, China, and Southeast Asia. Growing affordability and awareness are key contributors.

Latin America & Middle East/Africa

These regions show emerging growth trends fueled by improving healthcare access, rising investments in vascular care, and growing patient awareness, though cost constraints remain a challenge.

Competitive Landscape

The peripheral interventions market is moderately consolidated, with leading players focusing on product innovation, regulatory approvals, and strategic partnerships. Key strategies include:

• Launch of next-generation drug-coated devices

• Acquisitions to expand vascular portfolios

• Increased investment in research and development

• Expansion into emerging markets

Prominent companies typically include manufacturers of stents, balloons, catheters, and atherectomy systems with strong global distribution networks.

Future Outlook

The peripheral interventions market is set for substantial expansion over the next decade, driven by increased disease burden, accelerated innovation in vascular technologies, and growing preference for minimally invasive care models. Emerging economies will present lucrative opportunities as healthcare systems continue strengthening and patient awareness rises.

With ongoing advancements in drug-delivery systems, smart stents, AI-enabled imaging tools, and robotic-assisted interventions, the industry is poised for a significant transformation that enhances clinical outcomes and patient safety.

About Kings Research

Kings Research is a leading market research and consulting firm that provides comprehensive market intelligence and strategic insights to businesses across various industries.

Explore More Articles:

Inside Japan’s Adtech Transformation: How Adaptive Streaming Is Solving the Performance vs. Experience Paradox

Deepfake Defence in Japan: How Corporates Are Battling AI-Driven Social Engineering in a Low-Birth-Rate Economy